Literature DB >> 9399904

Spectrum of mutations in the RPGR gene that are identified in 20% of families with X-linked retinitis pigmentosa.

M Buraczynska1, W Wu, R Fujita, K Buraczynska, E Phelps, S Andréasson, J Bennett, D G Birch, G A Fishman, D R Hoffman, G Inana, S G Jacobson, M A Musarella, P A Sieving, A Swaroop.   

Abstract

The RPGR (retinitis pigmentosa GTPase regulator) gene for RP3, the most frequent genetic subtype of X-linked retinitis pigmentosa (XLRP), has been shown to be mutated in 10%-15% of European XLRP patients. We have examined the RPGR gene for mutations in a cohort of 80 affected males from apparently unrelated XLRP families, by direct sequencing of the PCR-amplified products from the genomic DNA. Fifteen different putative disease-causing mutations were identified in 17 of the 80 families; these include four nonsense mutations, one missense mutation, six microdeletions, and four intronic-sequence substitutions resulting in splice defects. Most of the mutations were detected in the conserved N-terminal region of the RPGR protein, containing tandem repeats homologous to those present in the RCC-1 protein (a guanine nucleotide-exchange factor for Ran-GTPase). Our results indicate that mutations either in as yet uncharacterized sequences of the RPGR gene or in another gene located in its vicinity may be a more frequent cause of XLRP. The reported studies will be beneficial in establishing genotype-phenotype correlations and should lead to further investigations seeking to understand the mechanism of disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399904      PMCID: PMC1716085          DOI: 10.1086/301646

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  14 in total

1.  Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line.

Authors:  G T Drivas; A Shih; E Coutavas; M G Rush; P D'Eustachio
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

2.  Analysis of the RPGR gene in 11 pedigrees with the retinitis pigmentosa type 3 genotype: paucity of mutations in the coding region but splice defects in two families.

Authors:  R Fujita; M Buraczynska; L Gieser; W Wu; P Forsythe; M Abrahamson; S G Jacobson; P A Sieving; S Andréasson; A Swaroop
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

3.  X-linked retinitis pigmentosa.

Authors:  A C Bird
Journal:  Br J Ophthalmol       Date:  1975-04       Impact factor: 4.638

4.  X-linked retinitis pigmentosa. Profile of clinical findings.

Authors:  G A Fishman; M D Farber; D J Derlacki
Journal:  Arch Ophthalmol       Date:  1988-03

5.  Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene.

Authors:  S G Jacobson; M Buraczynska; A H Milam; C Chen; M Järvaläinen; R Fujita; W Wu; Y Huang; A V Cideciyan; A Swaroop
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-09       Impact factor: 4.799

6.  Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome.

Authors:  B Knebelmann; C Breillat; L Forestier; C Arrondel; D Jacassier; I Giatras; L Drouot; G Deschênes; J P Grünfeld; M Broyer; M C Gubler; C Antignac
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

7.  Positional cloning of the gene for X-linked retinitis pigmentosa 3: homology with the guanine-nucleotide-exchange factor RCC1.

Authors:  R Roepman; G van Duijnhoven; T Rosenberg; A J Pinckers; L M Bleeker-Wagemakers; A A Bergen; J Post; A Beck; R Reinhardt; H H Ropers; F P Cremers; W Berger
Journal:  Hum Mol Genet       Date:  1996-07       Impact factor: 6.150

8.  Isolation and characterization of the active cDNA of the human cell cycle gene (RCC1) involved in the regulation of onset of chromosome condensation.

Authors:  M Ohtsubo; R Kai; N Furuno; T Sekiguchi; M Sekiguchi; H Hayashida; K Kuma; T Miyata; S Fukushige; T Murotsu
Journal:  Genes Dev       Date:  1987-08       Impact factor: 11.361

9.  Localizing multiple X chromosome-linked retinitis pigmentosa loci using multilocus homogeneity tests.

Authors:  J Ott; S Bhattacharya; J D Chen; M J Denton; J Donald; C Dubay; G J Farrar; G A Fishman; D Frey; A Gal
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

10.  A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3).

Authors:  A Meindl; K Dry; K Herrmann; F Manson; A Ciccodicola; A Edgar; M R Carvalho; H Achatz; H Hellebrand; A Lennon; C Migliaccio; K Porter; E Zrenner; A Bird; M Jay; B Lorenz; B Wittwer; M D'Urso; T Meitinger; A Wright
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

View more
  32 in total

Review 1.  The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment.

Authors:  G B Arden
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

2.  A fifth locus for Bardet-Biedl syndrome maps to chromosome 2q31.

Authors:  T L Young; L Penney; M O Woods; P S Parfrey; J S Green; D Hefferton; W S Davidson
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

3.  RPGR-ORF15, which is mutated in retinitis pigmentosa, associates with SMC1, SMC3, and microtubule transport proteins.

Authors:  Hemant Khanna; Toby W Hurd; Concepcion Lillo; Xinhua Shu; Sunil K Parapuram; Shirley He; Masayuki Akimoto; Alan F Wright; Ben Margolis; David S Williams; Anand Swaroop
Journal:  J Biol Chem       Date:  2005-07-25       Impact factor: 5.157

4.  Disruption of RPGR protein interaction network is the common feature of RPGR missense variations that cause XLRP.

Authors:  Qihong Zhang; Joseph C Giacalone; Charles Searby; Edwin M Stone; Budd A Tucker; Val C Sheffield
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-08       Impact factor: 11.205

5.  Mutations of 60 known causative genes in 157 families with retinitis pigmentosa based on exome sequencing.

Authors:  Yan Xu; Liping Guan; Tao Shen; Jianguo Zhang; Xueshan Xiao; Hui Jiang; Shiqiang Li; Jianhua Yang; Xiaoyun Jia; Ye Yin; Xiangming Guo; Jun Wang; Qingjiong Zhang
Journal:  Hum Genet       Date:  2014-06-18       Impact factor: 4.132

6.  A novel locus (RP24) for X-linked retinitis pigmentosa maps to Xq26-27.

Authors:  L Gieser; R Fujita; H H Göring; J Ott; D R Hoffman; A V Cideciyan; D G Birch; S G Jacobson; A Swaroop
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

7.  Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease.

Authors:  Kari Branham; Mohammad Othman; Matthew Brumm; Athanasios J Karoukis; Pelin Atmaca-Sonmez; Beverly M Yashar; Sharon B Schwartz; Niamh B Stover; Karmen Trzupek; Dianna Wheaton; Barbara Jennings; Maria Laura Ciccarelli; K Thiran Jayasundera; Richard A Lewis; David Birch; Jean Bennett; Paul A Sieving; Sten Andreasson; Jacque L Duncan; Gerald A Fishman; Alessandro Iannaccone; Richard G Weleber; Samuel G Jacobson; John R Heckenlively; Anand Swaroop
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

8.  RP2 and RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa.

Authors:  Dror Sharon; Michael A Sandberg; Vivian W Rabe; Melissa Stillberger; Thaddeus P Dryja; Eliot L Berson
Journal:  Am J Hum Genet       Date:  2003-10-16       Impact factor: 11.025

9.  Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations.

Authors:  Tomas S Aleman; Artur V Cideciyan; Alexander Sumaroka; Sharon B Schwartz; Alejandro J Roman; Elizabeth A M Windsor; Janet D Steinberg; Kari Branham; Mohammad Othman; Anand Swaroop; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

10.  Mutations in the X-linked retinitis pigmentosa genes RPGR and RP2 found in 8.5% of families with a provisional diagnosis of autosomal dominant retinitis pigmentosa.

Authors:  Jennifer D Churchill; Sara J Bowne; Lori S Sullivan; Richard Alan Lewis; Dianna K Wheaton; David G Birch; Kari E Branham; John R Heckenlively; Stephen P Daiger
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-19       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.